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1. Introduction
  Escherichia coli (E. coli) is, really, not an unpopular 
bacterium among members of the Enterobacteriaceae as well 
as members of other bacterial families[1,2]. The organism is a 
potential isolate from most clinical specimens subjected to 
bacteriological cultures and non-invasive conditions such 
as food poisoning[3-5]. E. coli has several inherent virulent 
factors that that tend to trigger process of infection and to 
a large extent influence the pathogenesis of its diseases in 
various parts of the human body[6,7]. These include fimbriae, 
flagella, outer membrane proteins, lipopolysaccharide, 
capsule antigen, urease, immunoglobulin A proteases, 
haemolysins and amino acid deaminases[8-10].
  Quite a large number of the E. coli strains isolated from 
clinical specimens in contemporary medical practice 
have been found to be beta-Lactamase producing, and 
hydrolysing the same drugs meant for their treatment[11-13]. 
And with the emergence of a newer variant of the organism 
called- expanded-spectrum beta-Lactamase-producing 
strains of E. coli. Treatment failure from widespread 
resistance against several antimicrobials is gradually 
assuming a significant feature of the organism[14,15]. The 
expanded resistant isolates from nosocomial infections have 
continued to consistently prove more difficult to be treated 
compared to their community-acquired counterpart[16,17].
Objective: To ascertain the antibiotic susceptibility patterns of Escherichia coli recovered from 
blood culture specimens in Calabar, Nigeria. Methods: The study was retrospective in nature 
and was carried out at University of Calabar Teaching Hospital (UCTH) Calabar. Data generated 
from blood culture specimens over a five year period (Feb. 2004-Feb. 2009) was compiled, 
relevant information such as age, sex, organism recovered and antibiotic susceptibility patterns 
were obtained from patients records. Samples were collected, transported, stored and processed 
using standard laboratory procedures. Data obtained was analysed using Epi Info 6 statistical 
software. Results: Escherichia coli was responsible for 15.3% (31/203) of the blood infections 
being the third most common microorganism encountered. The community acquired (CA) isolates 
of the organism were significantly less resistant (P<0.05), compared to the nosocomial (NC) 
isolates against ampicillin, cloxacillin, amoxicillin, tetracycline, co-trimoxazole, chloramphenicol 
and erythromycin. The sensitivity of both the NC and CA isolates of Escherichia coli to amikacin, 
augmentin, ofloxacin, ciprofloxacin, ceftazidime, cefuroxime, ceftriaxone and rifampicin was 
generally high (80-100%) with no significant difference (P>0.05). Majority (>95.0%) of the NC 
isolates of Escherichia coli were resistant to six of the antibiotics tested. Conclusions: Control 
mechanisms for hospital acquired infections should be stepped up so as to limit the spread of the 
highly resistant bacterial strains. Also the sale and consumption of antibiotics by the public need 
to be regulated.
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  The paradigm shift in the antimicrobial susceptibility 
profile of E. coli among humans as serially documented 
across the globe calls for the need for a periodic review 
of its antimicrobial susceptibility patterns at local health 
institutions. This would make up-to-date information on 
the above issue available concerning the organism and 
hence offer useful guide in the choice of antibiotics for the 
treatment of its infections and associated ailments such as 
life threatening septicaemia. 
2. Materials and methods
  The study was carried out at University of Calabar 
Teaching Hospital (UCTH), situated in Calabar city, the 
capital of Cross Rivers state, south-south Nigeria. 
  It was retrospective in nature, and data generated from the 
antibiotic susceptibility pattern of bacteria recovered from 
blood culture specimens were compiled for a period of five 
years (1st February, 2004-31st January, 2009). Specimens 
were collected, transported, stored and processed using 
standard laboratory procedures[18]. Briefly, using sterile 
procedures 2-4 mL of blood were collected and introduced 
into separate blood culture bottles (containing brain 
heart infusion and thioglycolate broths) and incubated for 
subsequent subcultures, Gram staining and biochemical 
methods. Modified Kirby-Bauer’s diffusion method was 
used to carry out susceptibility testing[19]. Microorganisms 
recovered were grouped into nosocomial or community 
acquired based on the epidemiological circumstance of the 
blood specimens. Other relevant information such as age, 
sex were obtained from patients records.
  The results were analysed using Epi Info-6, statistical 
software, P values ≤ 0.05 were considered significant.
3. Results
  Of the 3 255 blood culture specimens processed during the 
study period, 203 bacterial isolates were recovered of which 
E. coli was responsible for 15.3% (n=31) of the infections. 
Other bacteria recovered were: Staphylococcus aureus 22.7% 
(n=46), Coagulase negative Staphylococci (CONS) 14.3% 
(n=29), Proteus species 11.3% (n=23), Klebsiella species 
20.2% (n=41), Salmonella typhi/paratyphi 10.3% (n=21) 
and Citrobacter/Enterobacter spp. 4.4% (n=9). Community 
acquired (CA) and nosocomial (NC) isolates of E. coli 
recovered were 61.3% (19) and 38.7% (12), respectively.
  Based on age, the rate of E. coli infection in the blood was 
found to be highest among those aged 70-79 (7, 22.6%). 
There were 6 in age group of 40-49 years (19.4%), 5 both in 
10-19 and 60-69 years old group, respectively (16.1%), 3 in 
20-29 years old (9.7%),  2 in 0-9 and 30-59 years old group, 
respectively (6.5%). Those with 30-39 years old (1, 3.2%) had 
the lowest number of E. coli isolates recovered from their 
blood (P>0.05)(Table 1).
  Antimicrobial susceptibility pattern of isolates of E. 
coli recovered from blood culture specimens against the 
antimicrobial agents tested showed that both the NC and CA 
isolates of organism were all (100%) susceptible to ofloxacin, 
ciprofloxacin, ceftazidime and cefuroxime but only the 
CA and NC isolates were susceptible (100%) to augmentin 
and rifampicin, respectively. The susceptibility of both 
the NC and CA isolates of E. coli were generally below 
60% to penicillin G, ampicillin, cloxacillin, amoxicillin, 
tetracycline, co-trimoxazole, chloramphenicol and 
erythromycin with also significantly higher resistance of the 
NC compared to the CA isolates of the organism against the 
same group of antibiotics (P<0.05). There was no significant 
difference in the sensitivity of both the CA and NC isolates 
of the organism against augmentin, colistin, streptomycin, 
gentamicin, amikacin, ceftriaxone and rifampicin (P>0.05)
(Figure 1).
Figure 1. Antimicrobial susceptibility pattern of E. coli recovered 
from blood culture specimens in Calabar, Nigeria.
PEN=Penicil l in G, AMP= Ampicil l in,  CLX=Cloxacil l in, 
AMX= Amoxicillin, TET=Tetracycline, COT=Cot-trimoxazole, 
CHL=Chloramphenicol, ERY=Erythromycin, RIF=Rifampicin, *= P> 
0.05 
Table 1 
Age and gender distribution of E. coli recovered from blood culture 
specimens in Calabar, Nigeria [n(%)].
Age interval (Years old) *   Male **  Female    Total 
0-9   0 (0.0)   2 (6.5)   2 (6.5)
10-19   4 (12.9)   1 (3.2)   5 (16.1)
20-29   3 (9.7)   0 (0.0)   3 (9.7)
30-39   1 (3.2)   0 (0.0)   1 (3.2)
40-49   4 (12.9)   2 (6.5)   6 (19.3)
50-59   0 (0.0)   2 (6.5)   2 (6.5)
60-69   1 (3.2)   4 (12.9)   5 (16.1)
70-79   2 (6.5)   5 (16.1)   7 (22.6)
曒80   0 (0.0)   0 (0.0)   0 (0.0)
Unclassified   0 (0.0)   0 (0.0)   0 (0.0)
Total 15 (48.3) 16 (51.7) 31 (100)
*X2 (Yates Corrected)= 0.02, OR= 0.94, RR=0.96, P= 0.90;
**X2 (Yates Corrected)= 0.51, OR=0.73, RR=0.76, P= 0.47.
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4. Discussion
  E. coli was the third most common microorganism 
recovered and was found to account for 15% of the entire 
blood infections with no significant gender or age difference, 
though more isolates were recovered from paediatric and 
elderly patients. These findings compare well with that of 
Moreno et al in Spain[20] Ling et al in China[21], Blomberg et 
al in Tanzania[22] and Mugalu et al in Uganda[23] where E. 
coli was among the commonest microorganisms recovered 
from blood in various proportions. The finding of E. coli 
as the commonest agent causing blood infections in South 
Korea[24] and Italy[25] also partly agrees with findings from 
the present study. The inherent virulent factors that tend to 
accentuate survival of the organism in human tissues. Its 
ability to trigger quick release of cytokines and the rapid 
progression of its associated septic shock calls for the need 
for prompt management of its bacterial colonization[6-9].
  All the CA and NC isolates of E. coli were sensitive 
(100%) to ofloxacin, ciprofloxacin, ceftazidime and 
cefuroxime while only the NC isolates were 100% sensitive 
to amikacin and ceftriaxone. Also the sensitivity of both 
the CA and NC isolates of the organism ranged from 0-60% 
against penicillin G, ampicillin, cloxacillin, amoxicillin, 
tetracycline, co-trimoxazole, chloramphenicol and 
erythromycin which this same group of antibiotics recorded 
significantly higher resistance among the NC isolates 
compared to the CA (P<0.05). This is a major deviation 
from the past where most of these antibiotics were at the 
disposal the physician to manage E. coli related infections. 
This paradigm shift in resistance pattern has similarly 
been documented in Jombo[26,27] in Nigeria. The fact that 
each E. coli isolate was resistant to at least 3 antimicrobials 
(range 3-6) calls for urgent need to regulate both sale 
and consumption of antibiotics in the country. This 
should probably include ban on free sale and purchase of 
antibiotics at will over the counter by the public the current 
norm is.
  The high activity generally recorded in the present study 
by quinolones and cephalosporins against E. coli has also 
been elaborately documented in Slovak republic[28], United 
Kingdom[29], Russia and Norway[30] and Spain[31]. Most of 
the E. coli isolates resistant to up to 6 antibiotics were NC 
in origin. There should be in place a more comprehensive 
policy for control of NC infections with proper monitoring, 
evaluation and surveillance[32,33]. This would limit the 
spread of highly resistant microorganisms in the hospital 
environment and also their probable spill over to the larger 
society with the attendant consequences[29-31].
  In conclusion, the present study has shown that, contrary 
to its favourable susceptibility pattern in the past, most of 
the E. coli recovered from blood especially the hospital 
acquired were resistant to up to six antibiotics. Quinolones, 
cephalosporins and aminoglycosides were generally the 
more active antibiotics against the organism in Calabar. 
A more comprehensive approach towards control of NC 
infections should be put in place so as to limit the degree 
of dissemination of the causative agents. In addition an 
integrated approach should be put in place to properly 
regulate both the sale and consumption of antibiotics so as 
to limit their abuse in the country. 
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